top of page

Dr. Perlis currently consults with Anavex Pharmaceuticals and is an expert advisor for Gerson Lehman Group and Guidepoint.

 

His work is largely focused on the sleep effects of drugs and devices that are in development.

In years past he has worked as a consult, advisor, or site investigator for:

  • Sanofi

  • Merck 

  • Eisai

  • Actelion

  • Takeda

  • Nexalin

  • Lumosity

  • MedQuery Advisors

  • Intelligentsia Consulting

  • InsomniSolv

bottom of page